Runway Growth Finance (RWAY) - 2025 Q3 - Quarterly Results

Investment Income - Total investment income for Q3 2025 was $36.7 million, unchanged from Q3 2024[4] - Net investment income for Q3 2025 was $15.7 million, or $0.43 per share, compared to $15.9 million, or $0.41 per share in Q3 2024[6] - For the three months ended September 30, 2025, total investment income was $36,747,000, slightly up from $36,651,000 in the same period of 2024[33] - Net investment income for the three months ended September 30, 2025, was $15,736,000, compared to $15,875,000 for the same period in 2024[33] Investment Portfolio - The investment portfolio had an aggregate fair value of $0.9 billion, comprising $878.8 million in loans and $67.2 million in equity-related investments[10] - The dollar-weighted annualized yield on average debt investments for Q3 2025 was 16.8%[5] - Total investments at fair value were $945,964,000, down from $1,076,840,000, with non-control/non-affiliate investments valued at $931,915,000[31] Financial Position - As of September 30, 2025, total assets amounted to $963,346,000, a decrease from $1,091,355,000 as of December 31, 2024[31] - Net asset value per share decreased by 0.8% to $13.55 as of September 30, 2025[13] - The net asset value per share as of September 30, 2025, was $13.55, down from $13.79 as of December 31, 2024[31] - Total liabilities decreased to $473,820,000 from $576,486,000 as of December 31, 2024[31] - The company’s credit facility debt was $186,000,000, reduced from $311,000,000[31] Investment Activity - The company completed 11 investments totaling $128.3 million during the quarter[7] - Net realized loss on investments was $1.3 million for Q3 2025, compared to no net realized gains or losses in Q3 2024[8] - The company reported a net increase in net assets resulting from operations of $8,019,000 for the three months ended September 30, 2025[33] Liquidity and Dividends - As of September 30, 2025, the company had approximately $371.9 million in available liquidity[14] - The company declared a fourth quarter 2025 dividend of $0.33 per share[3] Future Plans - The proposed acquisition of SWK Holdings is expected to enhance the company's healthcare and life sciences exposure[3] - The company plans to hold a conference call on November 6, 2025, to discuss its third quarter financial results[25]